Abstract
Area II of the 2014 Epilepsy Research Benchmarks aims to establish goals for preventing the development and progression of epilepsy. In this review, we will highlight key advances in Area II since the last summary of research progress and opportunities was published in 2016. We also highlight areas of investigation that began to develop before 2016 and in which additional progress has been made more recently.
Original language | English |
---|---|
Pages (from-to) | 14S-22S |
Journal | Epilepsy Currents |
Volume | 20 |
Issue number | 1_suppl |
DOIs | |
State | Published - Jan 1 2020 |
Bibliographical note
Funding Information:The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The authors gratefully acknowledge research funding from the NIH, NIH R37 NS 031348 (WF), NINDS NS103740 & NS065957 (D Boison).
Funding Information:
We would like to acknowledge the helpful feedback from the Epilepsy Leadership Council and other stewards from the NINDS/AES Epilepsy Research Benchmark Stewards Committee during the formulation of this manuscript. The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The authors gratefully acknowledge research funding from the NIH, NIH R37 NS 031348 (WF), NINDS NS103740 & NS065957 (D Boison).
Publisher Copyright:
© The Author(s) 2020.
Keywords
- NINDS benchmarks for epilepsy research
- benchmarks
- epilepsy
- epilepsy prevention
- epileptogenesis
- preventing epilepsy
- prevention clinical trials
- progress in epilepsy research
ASJC Scopus subject areas
- Clinical Neurology